NCT03452930View on ClinicalTrials.gov

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
GlioblastomaGliosarcomaMGMT-Unmethylated Glioblastoma
Interventions
RADIATION

Radiation Therapy

Undergo RT

DRUG

Tinostamustine

Given IV

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03452930 - Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma | Biotech Hunter | Biotech Hunter